MedPath

Etodolac

Generic Name
Etodolac
Brand Names
Lodine
Drug Type
Small Molecule
Chemical Formula
C17H21NO3
CAS Number
41340-25-4
Unique Ingredient Identifier
2M36281008

Overview

Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.

Background

Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.

Indication

For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.

Associated Conditions

  • Acute Pain
  • Chronic Back Pain
  • Extra-Articular Rheumatism
  • Juvenile Idiopathic Arthritis (JIA)
  • Muscle Spasms
  • Nonspecific Pain Post Traumatic Injury
  • Osteoarthritis (OA)
  • Postoperative pain
  • Rheumatoid Arthritis
  • Spinal Disorders

FDA Approved Products

Etodolac
Manufacturer:PD-Rx Pharmaceuticals, Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2023/04/28
NDC:43063-856
Etodolac
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:400 mg in 1 1
Approved: 2023/10/30
NDC:71335-2259
Etodolac
Manufacturer:Proficient Rx LP
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/01/01
NDC:71205-743
Etodolac
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:400 mg in 1 1
Approved: 2021/04/23
NDC:63629-8805
Etodolac
Manufacturer:PD-Rx Pharmaceuticals, Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2023/03/03
NDC:43063-578

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath